[Basic and clinical studies of serum CA195 antigen assay with "BL-CA195" kit]. 1993

M Kobayashi, and A Yamaguchi, and T Imai, and H Otake, and H Igarashi, and N Hatori, and K Tomiyoshi, and T Inoue, and K Endo, and H Sakahara
Department of Nuclear Medicine, Gunma University School of Medicine, Maebashi.

We performed basic and clinical studies of IRMA "BL-CA195" kit in which monoclonal antibody CC3C195 was used as 125I-labeled tracer and solid phase antibody. The reproducibility of the assay results and dilution curves were satisfactory. There was a close correlation between serum CA195 and CA19-9 values, and many patients with pancreatic and colorectal cancer had elevated serum CA195 concentrations. Unlabeled CC3C195 antibody dose-dependently and completely inhibited the binding of 125I-labeled anti-CA19-9 antibody to its corresponding antigen. These findings suggest that CA195 and CA19-9 share common antigenic determinants.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011933 Reagent Kits, Diagnostic Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use. Diagnostic Reagent Kits,Diagnostic Reagents and Test Kits,Diagnostic Test Kits,In Vitro Diagnostic Device,In Vitro Diagnostic Devices,In Vitro Diagnostic Medical Device,In Vitro Diagnostic Medical Devices,Kits, Diagnostic Reagent,Diagnostic Reagent Kit,Diagnostic Test Kit,Kit, Diagnostic Reagent,Kit, Diagnostic Test,Kits, Diagnostic Test,Reagent Kit, Diagnostic,Test Kit, Diagnostic,Test Kits, Diagnostic
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers

Related Publications

M Kobayashi, and A Yamaguchi, and T Imai, and H Otake, and H Igarashi, and N Hatori, and K Tomiyoshi, and T Inoue, and K Endo, and H Sakahara
June 1996, Kaku igaku. The Japanese journal of nuclear medicine,
M Kobayashi, and A Yamaguchi, and T Imai, and H Otake, and H Igarashi, and N Hatori, and K Tomiyoshi, and T Inoue, and K Endo, and H Sakahara
October 1989, Kaku igaku. The Japanese journal of nuclear medicine,
M Kobayashi, and A Yamaguchi, and T Imai, and H Otake, and H Igarashi, and N Hatori, and K Tomiyoshi, and T Inoue, and K Endo, and H Sakahara
August 1994, Kaku igaku. The Japanese journal of nuclear medicine,
M Kobayashi, and A Yamaguchi, and T Imai, and H Otake, and H Igarashi, and N Hatori, and K Tomiyoshi, and T Inoue, and K Endo, and H Sakahara
October 1989, Kaku igaku. The Japanese journal of nuclear medicine,
M Kobayashi, and A Yamaguchi, and T Imai, and H Otake, and H Igarashi, and N Hatori, and K Tomiyoshi, and T Inoue, and K Endo, and H Sakahara
July 1993, Kaku igaku. The Japanese journal of nuclear medicine,
M Kobayashi, and A Yamaguchi, and T Imai, and H Otake, and H Igarashi, and N Hatori, and K Tomiyoshi, and T Inoue, and K Endo, and H Sakahara
November 1982, Horumon to rinsho. Clinical endocrinology,
M Kobayashi, and A Yamaguchi, and T Imai, and H Otake, and H Igarashi, and N Hatori, and K Tomiyoshi, and T Inoue, and K Endo, and H Sakahara
September 1992, Kaku igaku. The Japanese journal of nuclear medicine,
M Kobayashi, and A Yamaguchi, and T Imai, and H Otake, and H Igarashi, and N Hatori, and K Tomiyoshi, and T Inoue, and K Endo, and H Sakahara
December 1988, Kaku igaku. The Japanese journal of nuclear medicine,
M Kobayashi, and A Yamaguchi, and T Imai, and H Otake, and H Igarashi, and N Hatori, and K Tomiyoshi, and T Inoue, and K Endo, and H Sakahara
March 1980, [Rinsho ketsueki] The Japanese journal of clinical hematology,
M Kobayashi, and A Yamaguchi, and T Imai, and H Otake, and H Igarashi, and N Hatori, and K Tomiyoshi, and T Inoue, and K Endo, and H Sakahara
October 1986, Kaku igaku. The Japanese journal of nuclear medicine,
Copied contents to your clipboard!